Unlocking Early Lung Cancer Detection with Florence

July 9, 2025

The National Lung Cancer Screening Program (NLCSP) Protocol is now available in Florence, helping healthcare professionals quickly assess whether patients meet the eligibility criteria for life-saving CT-scans. 

Built with simplicity in mind, this new protocol ensures all the necessary eligibility questions are asked and documented so you have all the information available to confirm that your patient is eligible for lung screening. This automated protocol simplifies the screening process, allowing you to focus more on patient care and less on paperwork.

Lung cancer is Australia’s biggest cancer killer – but early detection changes everything. Florence makes it easy to be part of the solution.

Why Florence?

Florence is your digital nurse assistant supporting chronic condition management. It’s simple, efficient, and fits seamlessly into your workflow. Florence’s human-like persona and friendly text messages make patients feel supported and understood, helping build trust and boost engagement. By using Florence, healthcare professionals can deliver consistent, compassionate care at scale – without adding to their workload.

For more information on Florence, the protocol, or to get started on Florence today, contact florence@semphn.org.au

National Lung Cancer Program

As of 1 July 2025, eligible Australians aged 50-70 can participate in the National Lung Cancer Screening Program. The program aims to improve health outcomes for Australians by increasing early detection of lung cancer and saving lives. 

Healthcare providers and the health support workforce will play a critical role in the delivery and success of the program by increasing understanding of and participation in the program.

Want to learn more?

Learn more about Florence and how to get started by visiting our Florence page or contact us at florence@semphn.org.au.  

Latest news

August 19, 2026
Every patient consultation provides an opportunity to review a patient’s immunisation history and vaccination status, while talking through any questions or concerns they may have about vaccination.
August 12, 2026
Recent vaccine supply and distribution issues have caused temporary vaccine shortages of the Capvaxive ® (pneumococcal) vaccine.
August 12, 2026
Throughout July and August, all Australians aged 50 will receive a letter, from the Australian Government Department of Health, Disability and Ageing, about reducing their dementia risk. Some patients may bring the letter or a dementia risk assessment report to appointments to ask questions or seek support.